Clinical Trial Update: A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers

View source ↗

Summary

A multicenter prospective observational study evaluating PriMatrix for the treatment of neuropathic diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• PriMatrix (acellular dermal matrix)

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Foot Ulcers, Diabetic | Status: COMPLETED